Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast‐derived ADAMTS‐7 and ‐12
Authors:
- Selene Pérez‐GarcíaSPSelene Pérez‐García
- Mar CarriónMCMar Carrión
- Raúl Villanueva‐RomeroRVRaúl Villanueva‐Romero
- Tamara Hermida‐GómezTHTamara Hermida‐Gómez
- Mercedes Fernández‐MorenoMFMercedes Fernández‐Moreno
- Mario MelladoMMMario Mellado
- Francisco J. BlancoFBFrancisco J. Blanco
- Yasmina JuarranzYasmina Juarranz
- Rosa P. GomarizRGRosa P. Gomariz
Open Access
- 22 March 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 23 (6) , 3974-3983
Abstract
Failure of therapeutic approaches for the treatment of osteoarthritis (OA) based on the inhibition of metalloproteinases, might be because of their constitutive expression in homeostasis, together with their network complexity. The knowledge of this network would contribute to selective target pathological conditions. In this sense, blockade of mediators produced by neighbouring joint cells, such as synovial fibroblasts (SF), would prevent cartilage damage. Thus, we studied the contribution of ADAMTS‐7 and ‐12 from SF to cartilage oligomeric matrix protein (COMP) degradation, and the signalling pathways involved in their expression. We report for the first time in SF, the involvement of ERK‐Runx2 axis and Wnt/β‐catenin signalling in ADAMTS‐12 and ADAMTS‐7 expressions, respectively, with the subsequent consequences in COMP degradation from cartilage extracellular matrix. After stimulation with IL‐1β or fibronectin fragments, we showed that ERK inhibition decreased Runx2 activation and ADAMTS‐12 expression in OA‐SF, also reducing Fn‐fs‐induced COMP degradation. Blockage of Wnt signalling by DKK1 reduced ADAMTS‐7 and COMP degradation in OA‐SF as well. In addition, Wnt7B expression was induced by IL‐1β and by itself, also increasing ADAMTS‐7. Our results could contribute to the development of disease‐modifying OA drugs targeting ADAMTS‐7 and ‐12 for the prevention of extracellular matrix components degradation like COMP.Keywords
Funding Information
- Instituto de Salud Carlos III (PI17/00027 and PI16/2124, RD16/0012/0002, RD16/0012/0006 and RD16/0012/0008)
This publication has 57 references indexed in Scilit:
- Proteases involved in cartilage matrix degradation in osteoarthritisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Effects of Wnt3A and mechanical load on cartilage chondrocyte homeostasisArthritis Research & Therapy, 2011
- Regulated Expression of ADAMTS-12 in Human Trophoblastic Cells: A Role for ADAMTS-12 in Epithelial Cell Invasion?PLOS ONE, 2011
- Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytesArthritis Research & Therapy, 2010
- The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinasesOpen Access Rheumatology: Research and Reviews, 2009
- In vitromodel for the analysis of synovial fibroblast-mediated degradation of intact cartilageArthritis Research & Therapy, 2009
- Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinOsteoarthritis and Cartilage, 2008
- Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signallingArthritis Research & Therapy, 2007
- ADAMTS-12 Associates with and Degrades Cartilage Oligomeric Matrix ProteinJournal of Biological Chemistry, 2006
- ADAMTS‐7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix proteinThe FASEB Journal, 2006